Skip to main content
Back
BJTRF logo

Beijing Tong Ren Tang Chinese Medicine Company Limited

Data quality: 100%
Overbought
BJTRF
OTC Healthcare Medical - Pharmaceuticals
$0.65
$0.00 (0.00%)
Mkt Cap: 542.78M
Day Range
$0.65 $0.65
52-Week Range
$0.65 $0.65
Volume
400
50D / 200D Avg
$0.65 / $0.65
Prev Close
$0.65

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 10.6 0.4
P/B 1.0 2.9
ROE % 9.6 3.7
Net Margin % 26.3 3.8
Rev Growth 5Y % -0.7 10.0
D/E 0.0 0.2

Key Takeaways

Revenue declined -0.65% annually over 5 years
Earnings declined -20.74% over the past year
Net margin of 26.25% shows strong profitability
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -260.42M
P/E of 10.64 — trading at a low valuation

Growth

Revenue Growth (5Y)
-0.65%
Revenue (1Y)-87.94%
Earnings (1Y)-20.74%
FCF Growth (3Y)N/A

Quality

Return on Equity
9.61%
ROIC8.23%
Net Margin26.25%
Op. Margin31.29%

Safety

Debt / Equity
0.03
Current Ratio19.65
Interest Coverage83.67

Valuation

P/E Ratio
10.64
P/B Ratio1.01
EV/EBITDA4.48
Dividend Yield0.07%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -87.94% Revenue Growth (3Y) -0.23%
Earnings Growth (1Y) -20.74% Earnings Growth (3Y) -69.27%
Revenue Growth (5Y) -0.65% Earnings Growth (5Y) -10.05%
Profitability
Revenue (TTM) 194.41M Net Income (TTM) 51.03M
ROE 9.61% ROA 8.52%
Gross Margin 61.16% Operating Margin 31.29%
Net Margin 26.25% Free Cash Flow (TTM) -260.42M
ROIC 8.23% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.03 Current Ratio 19.65
Interest Coverage 83.67 Dividend Yield 0.07%
Valuation
P/E Ratio 10.64 P/B Ratio 1.01
P/S Ratio 2.79 PEG Ratio -0.12
EV/EBITDA 4.48 Dividend Yield 0.07%
Market Cap 542.78M Enterprise Value 272.84M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 194.41M 1.61B 195.29M 221.60M 199.55M
Net Income 51.03M 64.38M 540.39M 82.68M 77.94M
EPS (Diluted) 0.06 0.60 0.08 0.10 0.09
Gross Profit 118.90M 1.07B 134.12M 139.02M 142.53M
Operating Income 60.84M 576.92M 79.93M 103.97M 98.80M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 598.72M 586.72M 567.74M 543.45M 494.82M
Total Liabilities 37.49M 40.29M 52.97M 64.85M 40.95M
Shareholders' Equity 537.98M 524.42M 495.03M 461.41M 438.31M
Total Debt 16.26M 15.89M 16.88M 13.20M 16.47M
Cash & Equivalents 286.19M 228.29M 128.04M 254.86M 212.90M
Current Assets 522.16M 510.31M 492.32M 471.47M 420.19M
Current Liabilities 26.57M 235.35M 42.24M 53.58M 27.32M